{"id":6513,"date":"2022-03-11T18:23:26","date_gmt":"2022-03-11T10:23:26","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=6513"},"modified":"2023-01-14T19:57:25","modified_gmt":"2023-01-14T11:57:25","slug":"the-board-of-directors-approved-the-convening-of-the-2022-annual-shareholders-meeting","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-approved-the-convening-of-the-2022-annual-shareholders-meeting\/","title":{"rendered":"The Board of Directors approved the convening of the 2022 Annual Shareholders’ Meeting."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a01<\/td>\nDate of announcement<\/td>\n2022\/03\/11<\/td>\nTime of announcement<\/td>\n18:23:19<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The Board of Directors approved the convening of\r\nthe 2022 Annual Shareholders' Meeting.<\/pre>\n<\/td>\n<\/tr>\n
Date of events2022\/03\/11<\/td>\n<\/td>\nTo which item it meets<\/td>\nparagraph 17<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of the board of directors' resolution:\r\n  2022\/03\/11\r\n2.Shareholders meeting date:2022\/06\/21\r\n3.Shareholders meeting location:1F,No. 168, \r\n  Minzu Rd.,Banqiao Dist.,New Taipei City, \r\n  Taiwan(R.O.C.)\r\n4.Shareholders meeting will be held by means of \r\n  (physical shareholders meeting\/ visual \r\n   communication assisted shareholders meeting \r\n   \/visual communication shareholders meeting):\r\n   physical shareholders meeting.\r\n5.Cause for convening the meeting \r\n(1)Reported matters:\r\n  (1)2021 business report and 2022 business \r\n     plan.\r\n  (2)Audit Committee's review report on the \r\n     2021 financial statements.\r\n  (3)2021 distribution report of employee \r\n     compensation and director remuneration.\r\n  (4)2021 distribution report of cash dividends.\r\n  (5)Report on the endorsement and guarantee \r\n     status.\r\n6.Cause for convening the meeting \r\n(2)Acknowledged matters:\r\n  (1)Adoption of 2021 financial statements.\r\n  (2)Adoption of 2021 earnings distribution.\r\n7.Cause for convening the meeting \r\n(3)Matters for Discussion:\r\n  (1)Issue new shares for capital increase by \r\n     earnings recapitalization.\r\n  (2)Amending part of the articles of the \r\n     Company's \u201cArticles of Incorporation\u201d.\r\n  (3)Amending part of the articles of the \r\n     Company's \u201cProcedures for Election of\r\n     Directors\u201d.\r\n  (4)Amending part of the articles of the \r\n     Company's \u201cOperational Procedures for\r\n     Acquisition and Disposal of Assets\u201d.\r\n  (5)Amending part of the articles of the\r\n     Company's \u201dOperational Procedures for\r\n     Endorsements and Guarantees\u201d.\r\n8.Cause for convening the meeting \r\n(4)Election matters:\r\n  Elect the 13th-term directors (including \r\n  independent directors).\r\n9.Cause for convening the meeting \r\n(5)Other Proposals:\r\n  Release the prohibition on directors from \r\n  participation in competition businesses.\r\n10.Cause for convening the meeting \r\n(6)Extemporary Motions:   None.\r\n11.Book closure starting date:2022\/04\/23\r\n12.Book closure ending date:2022\/06\/21\r\n13.Any other matters that need to be \r\n   specified:None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a01 Date of announcement 2022\/03\/11 Time of announcement 18:23:19 Subject The Board of Directors approved the convening of the 2022 Annual Shareholders’ Meeting. Date of events2022\/03\/11 To which item it meets paragraph 17 Statement 1.Date of the board of directors’ resolution: 2022\/03\/11 2.Shareholders meeting date:2022\/06\/21 3.Shareholders meeting location:1F,No. 168, Minzu Rd.,Banqiao Dist.,New Taipei …<\/p>\n
  The Board of Directors approved the convening of the 2022 Annual Shareholders’ Meeting.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[102,72],"tags":[],"class_list":["post-6513","post","type-post","status-publish","format-standard","hentry","category-material-information","category-investors"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=6513"}],"version-history":[{"count":14,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6513\/revisions"}],"predecessor-version":[{"id":6981,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6513\/revisions\/6981"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=6513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=6513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=6513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}